Literature DB >> 26016461

Pattern and profile of chronic liver disease in acute on chronic liver failure.

Zaigham Abbas1, Lubna Shazi.   

Abstract

The etiology of the chronic liver disease (CLD) in patients with acute on chronic liver failure (ACLF) may vary from region to region. The major cause of underlying CLD is viral (hepatitis B and C) in the East, while it is alcohol related in the West and in some parts of the Indian subcontinent. Autoimmune liver disease and Wilson's disease are the major underlying etiologies in the pediatric age group. The patients with CLD without cirrhosis should be included when defining ACLF. Non-alcoholic fatty liver disease related chronic liver insult in patients with known risk factors for progressive disease should be taken as a chronic liver disease in the setting of ACLF, whereas fatty liver with normal aminotransferases in low risk patients should not. The patients with CLD and previous decompensation should be excluded. Diagnosis of chronic liver disease in the setting of ACLF is made by history, physical examination and previously available or recent laboratory, endoscopic or radiological investigations. A liver biopsy through the transjugular route may help in cases where the presence of underlying CLD or its cause is not clear. The need of liver biopsy in ACLF should, however, be individualized. Standardization of liver biopsy assessment is essential for a uniform approach to the diagnosis and treatment of CLD and acute insult. Tools to measure liver stiffness may aid in identifying patients with advanced fibrosis. Studies are needed to validate the performance of these tests in the setting of ACLF.

Entities:  

Mesh:

Year:  2015        PMID: 26016461     DOI: 10.1007/s12072-015-9627-z

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  85 in total

1.  A position statement on NAFLD/NASH based on the EASL 2009 special conference.

Authors:  Vlad Ratziu; Stefano Bellentani; Helena Cortez-Pinto; Chris Day; Giulio Marchesini
Journal:  J Hepatol       Date:  2010-05-07       Impact factor: 25.083

2.  Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis.

Authors:  Paolo Angeli; Ezequiel Rodríguez; Salvatore Piano; Xavier Ariza; Filippo Morando; Elsa Solà; Antonietta Romano; Elisabet García; Marco Pavesi; Alessandro Risso; Alexander Gerbes; Chris Willars; Mauro Bernardi; Vicente Arroyo; Pere Ginès
Journal:  Gut       Date:  2014-10-13       Impact factor: 23.059

Review 3.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

4.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Authors:  Laurent Castéra; Julien Vergniol; Juliette Foucher; Brigitte Le Bail; Elise Chanteloup; Maud Haaser; Monique Darriet; Patrice Couzigou; Victor De Lédinghen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

Review 5.  Liver biopsy interpretation for the gastroenterologist.

Authors:  E M Brunt
Journal:  Curr Gastroenterol Rep       Date:  2000-02

6.  Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients with acute-on-chronic liver failure.

Authors:  Hitendra Garg; Ashish Kumar; Vishal Garg; Manoj Kumar; Ramesh Kumar; Barjesh Chander Sharma; Shiv Kumar Sarin
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

7.  Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity.

Authors:  Elisa Fabbrini; Faidon Magkos; B Selma Mohammed; Terri Pietka; Nada A Abumrad; Bruce W Patterson; Adewole Okunade; Samuel Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

8.  Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers.

Authors:  Indra Neil Guha; Julie Parkes; Paul Roderick; Dipanker Chattopadhyay; Richard Cross; Scott Harris; Philip Kaye; Alastair D Burt; Steve D Ryder; Guruprasad P Aithal; Christopher P Day; William M Rosenberg
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

9.  Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases.

Authors:  Bin-Wei Duan; Shi-Chun Lu; Meng-Long Wang; Jin-Ning Liu; Ping Chi; Wei Lai; Ju-Shan Wu; Qing-Liang Guo; Dong-Dong Lin; Yuan Liu; Dao-Bing Zeng; Chuan-Yun Li; Qing-Hua Meng; Hui-Guo Ding; Xin-Yue Chen; Hui-Yu Liao; Lie-Qing Ma; Yu Chen; Jing Zhang; Hai-Ping Xiang; Zhong-Ping Duan; Ning Li
Journal:  J Surg Res       Date:  2013-03-26       Impact factor: 2.192

10.  CLIF-SOFA scoring system accurately predicts short-term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis.

Authors:  Minjong Lee; Jeong-Hoon Lee; Sohee Oh; Yoonhyuk Jang; Wonik Lee; Hyung Joo Lee; Jeong-Ju Yoo; Won-Mook Choi; Young Youn Cho; Yuri Cho; Dong Hyeon Lee; Yun Bin Lee; Su Jong Yu; Nam-Joon Yi; Kwang-Woong Lee; Yoon Jun Kim; Jung-Hwan Yoon; Kyung-Suk Suh; Hyo-Suk Lee
Journal:  Liver Int       Date:  2014-10-01       Impact factor: 5.828

View more
  7 in total

Review 1.  Catalase and nonalcoholic fatty liver disease.

Authors:  Su-Kyung Shin; Hyun-Woo Cho; Seung-Eun Song; Dae-Kyu Song
Journal:  Pflugers Arch       Date:  2018-08-17       Impact factor: 3.657

2.  Proton Pump Inhibitor Therapy Increases the Risk of Spontaneous Bacterial Peritonitis in Patients with HBV-Related Acute-on-Chronic Liver Failure.

Authors:  Meng Zhang; Xin Xu; Wei Liu; Zhongwei Zhang; Qiuyu Cheng; Zhongyuan Yang; Tingting Liu; Yunhui Liu; Qin Ning; Tao Chen; Junying Qi
Journal:  Adv Ther       Date:  2021-07-25       Impact factor: 3.845

Review 3.  Pharmacotherapies for fatigue in chronic liver disease (CLD): a systematic review and meta-analysis (protocol).

Authors:  Andem Effiong; Prerna Kumari
Journal:  Syst Rev       Date:  2018-02-14

Review 4.  Acute-on-chronic liver failure: an update.

Authors:  Ruben Hernaez; Elsa Solà; Richard Moreau; Pere Ginès
Journal:  Gut       Date:  2017-01-04       Impact factor: 23.059

Review 5.  Insulin-Like Growth Factor (IGF) System in Liver Diseases.

Authors:  Agnieszka Adamek; Aldona Kasprzak
Journal:  Int J Mol Sci       Date:  2018-04-27       Impact factor: 5.923

Review 6.  Mesenchymal Stem Cell Transplantation for Liver Cell Failure: A New Direction and Option.

Authors:  Yantian Cao; Bangjie Zhang; Rong Lin; Qingzhi Wang; Jie Wang; Fangfang Shen
Journal:  Gastroenterol Res Pract       Date:  2018-03-04       Impact factor: 2.260

7.  Population-representative Incidence of Acute-On-Chronic Liver Failure: A Prospective Cross-Sectional Study.

Authors:  Gang Qin; Jian-Guo Shao; Yong-Chang Zhu; Ai-Dong Xu; Jian-Hua Yao; Xu-Lin Wang; Yin-Kun Qian; Hua-Yu Wang; Yi Shen; Peng Lu; Lu-Jun Wang
Journal:  J Clin Gastroenterol       Date:  2016-09       Impact factor: 3.062

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.